RxDoctor Payments Data

Danielle Zheng

Pain Medicine · Pittsburgh, PANPI 1215391800

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (58.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 45.6% of the total. Reporting peaked in 2020 at $6,697 and has fallen 88.4% since, to $775 in 2025.

$9,893in general payments, 2019–2025

Across 91 payments — averaging $108.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Abbott$3K
  • Tersera Therapeutics LLC$586
  • Nevro Corp.$321
  • Boston Scientific$241
  • Curonix LLC$150
  • plus $805 from 14 others

What the payments were for

  • Grants$5,80059%
  • Travel & lodging$1502%
  • Food & beverage$3,86439%
  • Education$801%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,893 in reported general payments places this provider in the 85th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$56,691
Medicare patients
170
Services billed
658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin274$4,091
Pregabalin55$1,410
Duloxetine Hcl136$1,224
Methocarbamol129$915
Diclofenac Sodium23$685
Cyclobenzaprine Hcl77$539
Memantine Hcl18$478
Naltrexone Hcl17$472
Tizanidine Hcl52$258
Celecoxib21$162
Oxycodone Hcl23$157
Meloxicam21$135
Baclofen19$128
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$124
Hydromorphone Hcl14$72

Paid to pharmacies, not to this prescriber.

Other pain medicine in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →